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Adult Still’s Disease was ﬁrst described in 1971 by Bywaters in fourteen adult female patients who presented with symptoms
indistinguishable from that of classic childhood Still’s Disease (Bywaters, 1971) . George Still in 1896 ﬁrst recognized this triad of
quotidian(daily)fevers,evanescentrash,andarthritisinchildrenwithwhatlaterbecameknownasjuvenileinﬂammatoryarthritis
(Still,1990).AdultOnsetStill’sDisease(AOSD)isaninﬂammatoryconditionofunknownetiologycharacterizedbyanevanescent
rash, quotidian fevers, and arthralgias. Numerous infectious agents have been associated with its presentation. This case is to our
knowledge the ﬁrst presentation of AOSD in the setting of Rocky Mountain Spotted Fever. Although numerous infectious agents
have been suggested, the etiology of this disorder remains elusive. Nevertheless, infection may in fact play a role in triggering the
onset of symptoms in those with this disorder. Our case presentation is, to our knowledge, the ﬁrst case of Adult Onset Still’s
Disease associated with Rocky Mountain spotted fever (RMSF).
1.CaseReport
A twenty-one-year old white female was admitted to our
internal medicine service for arthralgias and myalgias of two
weeks duration. For the past week, she noted daily fevers and
almost simultaneous rash. Associated symptoms included
sore throat, nausea, and vomiting. Her arthralgias involved
her wrists, ankles, and knees bilaterally. Patient stated that
she had been hiking in the North Georgia Mountains in
March and removed a tick from her leg and her pubis
approximately three days before her joint symptoms began.
She was unaware of how long the tick had been on her body.
She denied noticing any rashes at the site of tick removal.
After about one week’s time, she noted feeling feverish and
that a rash had developed on her right thigh, arm, and torso
(see ﬁgure).
Past medical and surgical history was negative. Patient
admitted to occasional alcohol and tobacco abuse but denied
illicit drugs. She denied history of sexually transmitted
diseases other than Bacterial Vaginosis but admitted to
sexual abuse by recent ex-boyfriend. Current medications
included metronidazole prescribed by emergency room
physician, Tylenol, and Benadryl. Patient stated that peni-
cillin caused a “bad rash” as a child. Physical exam was as
follows.
Vital Signs. Blood Pressure was 142/72, pulse was 81 beats
per minute and regular, respiratory rate was 18 breaths per
minute, and temperature was 102 degrees Fahrenheit.
Oral exam revealed an erythematous pharynx without
tonsillar exudate, mild conjunctival injection, mild bilateral
cervical lymphadenopathy, and modestly tender abdomen
with a mildly enlarged spleen. Elbows, shoulders, hips, and
knee joints were tender to palpation and passive motion
bilaterally. A salmon colored raised rash was noted on her
trunk, arms, and legs (see Figures 1 and 2). Laboratory exam
w a sa sf o l l o w s .
WBC Count. 13.93Kcells/mm3 with a neutrophillic pre-
dominance (83%), Hemoglobin: 11.2gm%, Mean corpuscu-
larvolume:89.9fL,platelets:233K/mm3,AST:134U/L,ALT:
156U/L, LDH: 430U/L, CRP: 21.1mg/dL, ESR: 119mm/hr,
ANA and Rhematoid Factors were both negative. Blood
cultures were negative. Rocky Mountain Spotted Fever Titers
measured via Latex agglutination assay were positive at
1:16 on admission and increased to 1:64 on subsequent
testing. HIV test was negative. Blood and urine cultures
were negative. Serology for Mycoplasma and Chlamydia was
negative. Vaginal and rectal swabs for gonorrhea were nega-
tive. Computerized Tomography of the Abdomen and Pelvis2 Case Reports in Medicine
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was signiﬁcant for moderate splenomegaly and mesenteric
adenitis.
Hospital Course. Patient was admitted to the staﬀ medicine
service and received broad spectrum antibiotics including
doxycycline 100mg by mouth twice daily to cover tick borne
illnesses including RMSF. This resulted in improvement
in her joint symptoms but not in her fever or rash. Her
rising RMSF titers, elevated liver enzymes, and symptom
improvement with doxycycline were presumptive evidence
that RMSF was culprit. Our patient’s rash, however, was
not characteristic of RMSF and its ﬂuctuation with her
fever was also suspicious. Careful evaluation of the rash and
fever spikes revealed the quotidian nature of her disease (see
Figures 1 and 2).
We found that our patient’s current symptoms were
consistent with Yamaguchi criteria for Adult Onset Still’s
disease. We checked her ferritin level which came back
markedly elevated at 9362ng/mL. After discussion with our
Infectiousdiseaseandrheumatologicconsultantswestopped
antibiotics on day 7 and started the patient on naproxen
500mg twice daily. This resulted in prompt resolution of
her fevers and rash within 24 hours. Of interest, the patient
refused two subsequent doses and her symptoms recurred.
After reiterating the inﬂammatory nature of her disease,
the patient resumed her naproxen with another marked
abatement of her symptoms.
W ef e e lt h a to u rp a t i e n t ’ ss y m p t o m sw e r en o td u et o
RMSF, because the rash was salmon colored and worsened
withthefeverspikes.Furthermore,herpromptimprovement
of all symptoms with anti-inﬂammatory agents and not
doxycycline speaks against an infectious etiology. RMSF may
have just been the trigger to this inﬂammatory condition.
2. Discussion
Adult onset Still’s Disease (AOSD) is rare systemic inﬂam-
matory disorder of unknown etiology and pathogenesis.
Numerous infectious agents have been proposed as poten-
tial inciting factors. Viruses such as Epstein-Barr virus,
Coxsachievirus, adenovirus, inﬂuenza A, human herpes 6,
hepatitis B, hepatitis C, and parvovirus B19 have been
implicated in small case series [3]. Bacterial triggers may
include Chlamydia pneumonia, Mycoplasma pneumonia,
Yersinia enterocolitica, and Borrelia burgdorferi [4, 5]. These
associations suggest that this disease entity may be similar
to reactive arthritis [6]. Our patient represents to our
knowledge the ﬁrst case of AOSD associated with Rocky
Mountain Spotted Fever (RMSF).
2.1. Clinical Manifestations. AOSD classically presents with
high spiking fevers and systemic manifestations [7]. Char-
acteristic rash, joint or muscle pains, lymphadenopathy, and
abnormalities of liver function may be seen [8]. The fever
generally exceeds 39 deg C and is quotidian or double-
quotidian in nature, peaking in the late afternoon [9].
The typical rash is often described as evanescent, salmon
to pink colored, maculopapular occurring on the extremities
and trunk sparing the face. Histology is often nonspeciﬁc
but may demonstrate dermal invasion by lymphocytes and
histiocytes with perivascular inﬂammation [10].
Arthritis and arthralgias are found in the vast majority
of patients (64–100%) [11]. Ankles, knees, and wrists are the
most commonly involved joints but elbows, shoulders and
hips have also been described [12]. Wrist involvement may
include joint space narrowing and ankylosis within 3 years of
disease onset in some untreated cases [13]. Radiographs are
usually not helpful early on in the disease.
Hepatic involvement characterized by abnormal liver
f u n c t i o nt e s t sc a nb es e e ni nu pt o7 5 %o fp a t i e n t s[ 14].
Cardiac complications may include pericardial eﬀusions and
myocarditis [15]. Lung involvement may be represented by
pleural eﬀusions, ﬁbrosis, or rarely acute respiratory distress
syndrome [16].
2.2. Diagnosis. AOSD is a clinical diagnosis. Various diag-
nostic criteria have been developed including the Yamaguchi
[17], Cush [18], and Fautrel criteria [19]. Antinuclear
antibody (ANA) and Rheumatoid factor (RF) are classically
negative. Erythrocyte sedimentation rate (ESR) and C-
reactive protein (CRP) are usually positive reﬂecting the
inﬂammatory nature of this condition [11, 20]. A striking
neutrophilic (>80%) leukocytosis is often seen on bloodCase Reports in Medicine 3
work [10]. Hematophagic syndrome may be heralded by the
onset of pancytopenia and requires prompt immunosup-
pressive therapy [21]. Recently ferritin has been considered
indiagnosticcriteriareﬂectingitsroleinoxidativestress[19].
A serum ferritin threshold of greater than 1000ng/mL has
been used to suggest AOSD [22]. The glycosylated fraction
of serum ferritin has also been suggested as a more speciﬁc
marker of the inﬂammation in AOSD [22]. Low levels of
this fraction represents disease activity but cannot be used
to follow progression or response to treatment.
The diﬀerential diagnosis of AOSD is broad. Seroneg-
ative spondyloarthropathies, reactive arthritis, granuloma-
tous disorders, familial Mediterranean fever, and various
vasculidities may present similarly. Infections, malignancies,
and other rheumatologic conditions must be considered and
ruled out.
2.3. Treatment. NSAIDs, corticosteroids, and antirheumatic
agents are the cornerstones of therapy [11]. Intially NSAIDs
such as naproxen or indomethacin are tried. Between 50
and 75% of those with progressive or recurrent symptoms
will require steroids [10]. Patients with NSAID refractory
disease, pancytopenia, pericarditis, pleuritis, or elevated
liver function tests are particularly at risk for progression
without steroid treatment [23]. Novel agents such as anti-
TNF drugs, interleukin blockade, and intravenous gamma-
globulin (IVIG) have been tried in small studies with limited
success [24].
2.4. Course and Prognosis. T h r e ep a t t e r n so fd i s e a s ep r o g r e s -
sion have been described [24].
(1) Monocyclic involvement is characterized by systemic
symptoms of fever, rash, organomegaly, and seriosi-
tis. Most patients will have one episode of disease and
achieve remission within one year.
(2) Polycyclic pattern involves multiple recurrences that
may or may not aﬀect joints. Complete remission is
usuallyachievedbetweenﬂaresthatmaybeseparated
bymanyyears.Recurrencesareoftenmilderthanﬁrst
attack.
(3) Chronic articular pattern targets the joints primarily
with minimal to no systemic symptoms. Severe joint
destruction is often the end result in untreated cases.
2.5. Follow-Up with Our Case. Our patient was discharged
home on naproxen and with a follow-up appointment for
our staﬀ medicine resident and staﬀ rheumatology clinic.
She did not attend either. Two months later she presented
again to the Emergency Department with fever, rash, joint
pains,andbilateralpleuraleﬀusions.Theseweredrainedand
patient responded well to a course of steroids. Unfortunately,
her ferritin was not checked by the admitting hospitalist.
Radiographs of her involved joints were not revealing of
ankylosis. She was rescheduled for Rheumatology Clinic one
week after discharge. She again has not shown up for any of
her appointments.
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